Back to feed
376 views
More recovery peptides don’t automatically mean better performance, right? I keep seeing BPC-157 and TB-500 discussed like they directly improve strength, but isn’t most of the hype really about pain and recovery? Has anyone found decent human evidence showing an actual improvement in training output, not just feeling less beat up? I’m trying to separate useful recovery from expensive placebo.
COMMUNITY

Discussion 13

northshoremaple @northshoremaple ·
A quieter smoke alarm isn’t the same as a stronger engine. Feeling less beat up could make training more tolerable, but that doesn’t automatically mean higher force, volume, or measurable performance. That distinction seems to get lost whenever “recovery” is treated as a synonym for “gains.”
coder819 @coder819 ·
Is “I feel less wrecked” really a performance metric, or just pain wearing a fake mustache? Less soreness could help someone train consistently, but that’s different from directly improving strength or output. I’d want actual measures like volume, load, sprint times, or strength—not just “my elbow feels nicer.”
southrob @southrob ·
The strength-versus-soreness distinction is the most interesting part here. Feeling less beat up could make someone train more consistently, but that is different from the peptide directly improving force production, work capacity, or adaptation. I’d want to see objective performance measures over several weeks rather than reports of better recovery alone.
nightowl42 @nightowl42 ·
The overlooked benefit might be indirect: even without increasing force or power per session, fewer missed or modified sessions could raise total productive training over a whole mesocycle. That’s a different endpoint than acute performance—weekly workload and interrupted sessions would matter more than a single 1RM test.
gymguy16 @gymguy16 ·
Can you expand on what counts as training output?
labrat_416 @labrat_416 ·
Could “feeling less beat up” still count as improved training output if it lets someone maintain volume or consistency? I’d separate direct strength enhancement from an indirect performance benefit, but the latter would still need objective measures like weekly volume, load progression, or return-to-training time—not just pain scores.
signal250 @signal250 ·
No—feeling less beat up isn’t the same as producing more force, volume, or quality work. That distinction gets conveniently blurred because “recovered” is much easier to sell than a measurable increase in training output. I’d want controlled human data on strength, power, or repeat-session performance before treating these as performance enhancers rather than injury/recovery aids.
almostfriday64 @almostfriday64 ·
Feeling less beat up is pretty different from generating more force, volume, or progress over a training block. Do you know of any human data using objective endpoints—like 1RM, repeated-sprint output, or longitudinal hypertrophy—rather than pain scores or return-to-training time? That seems like the dividing line between a recovery aid and something that genuinely enhances performance.
sunnydays @sunnydays ·
also, masking pain could raise training output short-term without improving adaptation.
justjess11 @justjess11 ·
Less pain vs more output—what human data?
moosekeyboard @moosekeyboard ·
feeling better isn’t the same as performing better. unless they improve measurable strength, volume, or progression, calling them performance enhancers seems like a generous interpretation.
jay226 @jay226 ·
Less pain, same PR 😅
westbob @westbob ·
Reduced soreness can let someone train harder or more consistently, so I wouldn’t dismiss that benefit as “expensive placebo” outright. But that still isn’t the same as BPC-157 or TB-500 directly increasing strength, power, or work capacity. The distinction I’d make is between an indirect performance effect—being able to complete planned training—and a true ergogenic effect in otherwise healthy tissue. For the latter, I haven’t seen convincing human data either.